194 related articles for article (PubMed ID: 30844405)
1. Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.
Wolfe AD; Arnold DB; Chen XS
J Mol Biol; 2019 Mar; 431(7):1506-1517. PubMed ID: 30844405
[TBL] [Abstract][Full Text] [Related]
2. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
[TBL] [Abstract][Full Text] [Related]
3. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
[TBL] [Abstract][Full Text] [Related]
4. Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
Wang S; Kim K; Gelvez N; Chung C; Gout JF; Fixman B; Vermulst M; Chen XS
J Mol Biol; 2023 Dec; 435(24):. PubMed ID: 38708190
[TBL] [Abstract][Full Text] [Related]
5. RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer.
Shivalingappa PKM; Sharma V; Shiras A; Bapat SA
Mol Cell Biochem; 2021 Dec; 476(12):4493-4505. PubMed ID: 34499322
[TBL] [Abstract][Full Text] [Related]
6. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
[TBL] [Abstract][Full Text] [Related]
7. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
Fossat N; Tam PP
RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
[TBL] [Abstract][Full Text] [Related]
8. Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.
Carouge D; Blanc V; Knoblaugh SE; Hunter RJ; Davidson NO; Nadeau JH
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5425-33. PubMed ID: 27582469
[TBL] [Abstract][Full Text] [Related]
9. Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells.
Severi F; Conticello SG
RNA Biol; 2015; 12(4):389-97. PubMed ID: 25806564
[TBL] [Abstract][Full Text] [Related]
10. Live-Cell Quantification of APOBEC1-Mediated RNA Editing: A Comparison of RNA Editing Assays.
Chieca M; Torrini S; Conticello SG
Methods Mol Biol; 2021; 2181():69-81. PubMed ID: 32729075
[TBL] [Abstract][Full Text] [Related]
11. APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.
Soleymanjahi S; Blanc V; Davidson N
RNA; 2021 Jun; 27(8):876-90. PubMed ID: 34083494
[TBL] [Abstract][Full Text] [Related]
12. Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.
Rayon-Estrada V; Harjanto D; Hamilton CE; Berchiche YA; Gantman EC; Sakmar TP; Bulloch K; Gagnidze K; Harroch S; McEwen BS; Papavasiliou FN
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13296-13301. PubMed ID: 29167373
[TBL] [Abstract][Full Text] [Related]
13. C-to-U RNA Editing: From Computational Detection to Experimental Validation.
Lerner T; Kluesner M; Tasakis RN; Moriarity BS; Papavasiliou FN; Pecori R
Methods Mol Biol; 2021; 2181():51-67. PubMed ID: 32729074
[TBL] [Abstract][Full Text] [Related]
14. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.
Blanc V; Riordan JD; Soleymanjahi S; Nadeau JH; Nalbantoglu I; Xie Y; Molitor EA; Madison BB; Brunt EM; Mills JC; Rubin DC; Ng IO; Ha Y; Roberts LR; Davidson NO
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33445170
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs.
Rosenberg BR; Hamilton CE; Mwangi MM; Dewell S; Papavasiliou FN
Nat Struct Mol Biol; 2011 Feb; 18(2):230-6. PubMed ID: 21258325
[TBL] [Abstract][Full Text] [Related]
16. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
[TBL] [Abstract][Full Text] [Related]
17. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
Severi F; Chicca A; Conticello SG
Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
[TBL] [Abstract][Full Text] [Related]
18. Apobec-1 complementation factor regulates cell migration and apoptosis through Dickkopf1 by acting on its 3' untranslated region in MCF7 cells.
Yan X; Li Q; Ni D; Xie Y; He Q; Wan Q; Liu Y; Lyu Z; Mao Z; Zhou Q
Tumour Biol; 2017 Jun; 39(6):1010428317706218. PubMed ID: 28639893
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.
Grünewald J; Zhou R; Garcia SP; Iyer S; Lareau CA; Aryee MJ; Joung JK
Nature; 2019 May; 569(7756):433-437. PubMed ID: 30995674
[TBL] [Abstract][Full Text] [Related]
20. Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
Caval V; Jiao W; Berry N; Khalfi P; Pitré E; Thiers V; Vartanian JP; Wain-Hobson S; Suspène R
BMC Genomics; 2019 Nov; 20(1):858. PubMed ID: 31726973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
